Jamal Rana MD FACC/LinkedIn
Nov 11, 2025, 23:38
The Wall Street Journal Features Major AHA Trials on Cholesterol Breakthroughs
Jamal Rana, Professor in the Department of Clinical Science at Kaiser Permanente Bernard J. Tyson School of Medicine, posted on LinkedIn:
”Many reached out requesting access to read the full article. The story made it to the print version, given this was The Wall Street Journal’s main coverage of the biggest trials presented at AHA Scientific Sessions 2025. We are now in era where multiple options exist to aggressively treat LDL cholesterol in high-risk patients to prevent heart disease.
Link here.”
Stay updated with Hemostasis Today.
AHA
American College of Cardiology
American Heart Association
Atherosclerosis
Betsy McKay
Cardiology
Cholesterol
European Atherosclerosis Society
Health
Heart Disease
Heart Health
Hematology
Hemostasis
Hemostasis Today
Jamal Rana
Kaiser Permanente Bernard J. Tyson School of Medicine
Medicine
The Wall Street Journal
thrombosis
-
Sep 8, 2026, 16:14Heghine Khachatryan: Colombo 2026 Insights on Point-of-Care Ultrasound in Hemophilia Joint Care
-
Sep 8, 2026, 15:57Flora Peyvandi: Efficiency Meets Innovation in Hemophilia B Gene Therapy
-
Sep 8, 2026, 15:48Maxime Dely: Guillain-Barré Syndrome – What if the Key Lies in the Plasma?
-
Sep 8, 2026, 15:34Ron DePinho: A Negative Trial Highlights the Need for Precision in Cardiovascular Inflammation
-
Sep 8, 2026, 15:31Adil Yousaf: Thrombolysis Speed Matters, but Eligibility Comes First
-
Sep 8, 2026, 15:28Dhargam Aljebouri: First Molecularly Characterized Para-Bombay Phenotype in the Arab World
-
Sep 8, 2026, 15:27Mohd Ashhad: How Much Does Hemoglobin Increase After 1 Unit of PRBC?
-
Sep 8, 2026, 15:27Sanish Babu: The Hematocrit–Platelet Signal in Severe Dengue
-
Sep 8, 2026, 15:26Mary Kama: Climate-Informed Early Warning Systems for Sickle Cell Anaemia